CD71/Transferrin receptor has been reported to be associated with cell proliferation in both normal and neoplastic tissues and useful in predicting clinical behavior or response to therapy in a number of malignancies including breast cancer. This receptor is broadly distributed in carcinomas, sarcomas, leukemias, and lymphomas.
